We performed meta-analyses of randomized, control trials to assess the effects of seven analgesic therapies on postoperative pulmonary function after a variety of procedures: epidural opioid, epidural local anesthetic, epidural opioid with local anesthetic, thoracic versus lumbar epidural opioid, intercostal nerve block, wound infiltration with local anesthetic, and intrapleural local anesthetic. Measures of forced expiratory volume in 1 s (FEV,), forced vital capacity (FVC), vital capacity (VC), peak expiratory flow rate (PEFR), Pao,, and incidence of atelectasis, pulmonary infection, and pulmonary complications overall were analyzed. Compared with systemic opioids, epidural opioids decreased the incidence of atelectasis (risk ratio [RR] 0.53, 95% confidence interval [CI] 0.33-0.85) and had a weak tendency to reduce the incidence of pulmonaryinfections (RRO.53,95% CIO.18-1.53) and pulmonary complications overall (RR 0.51, 95% CI 0.20-1.33). Epidural local anesthetics increased Pao, (difference 4.56 mm Hg, 95% CI 0.058-9.075) and decreased the incidence of pulmonary infections (RR 0.36,95% CI 0.21-0.65) and pulmonary complications overall (RR 0.58,95% CI 0.42-0.80) compared with systemic opioids. Intercostal nerve blockade tends to improve pulmonary outcome measures (incidence of atelectasis: RR 0.65,95% CI 0.27-1.57, incidence of pulmonary complications overall: RR 0.47, 95% CI 0X3-1.22), but these differences did not achieve statistical significance. There were no clinically or statistically significant differences in the surrogate measures of pulmonary function (FEV,, FVC, and PEFR). These analyses support the utility of epidural analgesia for reducing postoperative pulmonary morbidity but do not support the use of surrogate measures of pulmonary outcome as predictors or determinants of pulmonary morbidity in postoperative patients. Implications: When individual trials are unable to produce significant results, it is often because of insufficient patient numbers. It may be impossible for a single institution to study enough patients. Meta-analysis is a useful tool for combining the data from multiple trials to increase the patient numbers. These meta-analyses confirm that postoperative epidural pain control can significantly decrease the incidence of pulmonary morbidity.
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(Anesth Analg 1998;86:598-612) P ostoperative pulmonary dysfunction may delay recovery and, if severe, can be life-threatening. Hypoxia may impair wound healing and cognitive function, the latter especially in the elderly. Atel-on the management of postoperative pain (4), we examined the scientific evidence related to possible beneficial effects of various pain therapies on respiratory function. We present meta-analyses of data from randomized, controlled trials (RCTs) that assess the effect of specific pain treatments on respiratory function in postoperative patients. Meta-analysis, defined as the quantitative synthesis of data from multiple trials, has become a scientific discipline with well described principles and methods (5-9). It uses an explicit, systematic approach to literature retrieval, combined with specific statistical methods to integrate and interpret the results of separate investigations to improve on the traditional subjective process of drafting a narrative review article. By combining the results of several studies, metaanalysis can increase the statistical strength of findings that may not be individually significant because of small patient numbers in the trials, and can clarify ambiguity. Meta-analysis is only valid if the studies combined are comparable in trial design, patient demographics, and therapy tested (10). Some studies are not used in the present meta-analysis because the study groups are not combinable with those in the majority of studies. Nevertheless, there was a sufficient number of combinable trials for several metaanalyses. Specifically, we examined techniques in common daily practice by evaluating trials comparing perioperative:
epidural opioids versus systemic opioid, epidural local anesthetics versus systemic opioid, epidural opioid versus local anesthetic versus systemic opioid, thoracic epidural opioid versus lumbar epidural opioid, intercostal nerve blocks versus systemic opioid, wound infiltration versus no wound infiltration, and intrapleural local anesthetic versus systemic opioid.
Methods

Retrieval
RCTs examining the influence of postoperative analgesia on postoperative pulmonary function were retrieved in the process of developing scientific evidence to formulate recommendations presented in a clinical practice guideline on the management of acute pain after medical and surgical procedures and trauma (4). The search strategy was developed in conjunction with the staff of the National Library of Medicine. We initially searched 12 different databases (including nursing, sociological, psychological, and pharmacological databases) as part of a broader search for evidence related to acute pain treatment. However, for the purpose of analyses of pulmonary function, all the articles that met the inclusion criteria (RCTs evaluating the effect of pain therapy on pulmonary function) came from MEDLINE. Therefore, only MEDLINE 1966 to 1995 was searched. The following search terms were used: random, pain-postoperative, respirat, ventilat, atelectasis (MeSH heading [mh]), carbon dioxide (mh), forced expiratory volume (mh), oxygen (mh), lung (ml-r), peak expiratory flow rate (mh), pulmonary (mh), and vital capacity (mh). This search strategy produced 121 possibly useful trials evaluating the effects of pain treatment on pulmonary function. All 121 studies were retrieved and read by two investigators ('JCB and DBC); 61 were not used in the analyses. Another 74 studies were identified from the references of the original 121 and examined; of these, 64 did not meet the criteria for inclusion in the analyses. If an author had produced several similar reports, we verified that the patients in the subsequent trials were different from those in the original trial by contacting the author (if this was not clear from the article). Of the 125 studies that were not suitable for analysis, 3 evaluated the same patients in multiple trials, 40 were found not to be RCTs, 5 did not provide satisfactory data despite being RCTs (e.g., they failed to provide any measures of variance), 53 used comparisons that were not encountered frequently enough to make meta-analysis worthwhile, and 24 did not provide specific data on pulmonary function. The remaining trials 65 trials used as a basis for the meta-analyses presented herein (from a total of 70 initially selected), which were found in sufficient number making the same treatment comparison, and assessing the same end points (see Appendix 1) (11-75). All data were extracted by one investigator (JCB) and verified by a second investigator (SdF). The 48 articles used in the meta-analyses are those containing combinable data and measures of variance (Table 1) .
Quality Assessment
A cross-section of the available trials was assessed for quality using the method of Chalmers and Smith (76) and Liberati et al. (77). The articles were read and scored by two blind readers (IFA and TCC) according to a standardized checklist that considers both internal (scientific) validity and external (generalizable) validity. We performed a sensitivity analysis to determine whether the exclusion of low-quality studies changed the results, which it did not, probably because the quality ratings varied little among studies. We therefore decided to ignore the quality rating, an approach that has been justified by Emerson et al. (78) .
Statistical Analysis
Measures of forced expired volume in 1 s (FEV,), forced vital capacity (FVC), peak expiratory flow rate (PEFR), Pao,, and incidences of atelectasis, pulmonary infiltrates, and pulmonary complications in general were analyzed. These measures were chosen for the analyses because they were used frequently in the trials. FEV,, FVC, PEFR, and Pao, are presented in the articles as means, usually with some measure of variance (e.g., SD). If an article reported measurements taken at multiple time points, the value at or near 24 h after surgery was selected for the analyses, because the 24-h time point was most often reported in these studies. FEV,, FVC, and PEFR were reported in liters or liters per minute. Pao, was reported either as millimeters of mercury or as kilopascals; to compare measurements, we converted kilopascals to millimeters of mercury. The incidence of atelectasis was reported as the number or proportion of patients who exhibited clinical or radiological evidence of atelectasis.
The Der Simonian and Laird random effects model was used to combine data for both continuous and dichotomous outcomes (79). The random effects model calculates a weighted average by incorporating both within-study variation (sampling error) and between-study variation (different treatment effects). Compared with the fixed effect model, which considers only the within-study variation, the random effect model generally gives a similar estimate but a wider confidence interval when heterogeneity of treatment effect is present.
Calculations for dichotomous outcome data (incidence of atelectasis, incidence of pulmonary complications, and incidence of pulmonary infections) were performed using the Meta-Analyst program (80). The overall risk ratios (the ratio of the event rate in the treatment group to the event rate in the control group) and their respective 95% confidence intervals are reported.
A random effects weighted mean difference method was used to pool continuous data of each of the relevant outcomes (FEV,, FVC, PEFR, and Pao,). A difference between treatment means and its correlated standard error of the difference were extracted from the original studies or calculated using the method described in Appendix 2. Some studies reported the treatment effect as the change from preoperative to postoperative values along with their respective standard errors of the difference. These results were used directly. Other studies reported only the actual mean values and the standard error of the mean for each treatment separately, before and after the operation. In this case, because the exact value of the correlation coefficient is unknown, we estimated the standard error by-carrying out the analyses using three different levels of correlation coefficient (p = 0.25, 0.5, 0.75). This approach was taken to test the sensitivity of the results to this unknown parameter. As suggested by the data, only positive correlation coefficients were used. Because the differences did not reach statistical significance at each correlation level, we present only the more conservative level, i.e., the lowest correlation (p = 0.25) in Table 1 . Calculations of continuous data were performed using Mathcad software (81).
Results
The results of the meta-analyses are presented in Table  1 . The only significant differences found are a decrease in the incidence of atelectasis when epidural opioid was compared with systemic opioid (risk ratio [ 
Review of Contributing Studies
The following is an overview of the contributing studies (Appendix 1), how their results and the results of our meta-analyses bear on each other, and the conclusions that we can draw from the meta-analyses (Table 1) .
Epidural Opioids Versus Systemic Opioids
We analyzed 24 studies that compared epidural opioid treatment with systemic opioid treatment (11-34). Pain relief was found to be significantly better with epidural opioid treatment in 9 of these studies, but in 13 other studies, there was no significant improvement in pain relief (Appendix 1). Several investigators reported a statistically significant improvement in one or more surrogate measures of pulmonary function (FEV,, FVC, and PEFR) (14,19,24,25,30-32), but others found either no difference or a trend toward improvement that did not reach statistical significance. When the data were pooled in the meta-analyses, none of the differences in surrogate measures reached statistical significance (Table 1) . On the other hand, the pooled difference in the incidence of atelectasis (measured in 11 studies) did reach statistical significance ( Fig. 1 ), even though it was only found to be significant in 3 of the individual studies (15,16,18). The difference in the incidence of pulmonary complications seems to tend toward statistical significance (4 studies) (Fig. 4) (see above).
Epidural Local Anesthetics Versus Systemic Opioids
Eleven papers contributed to these analyses (12,13,22,35-41). Most of the differences found by these investigators were positive, favoring the experimental treatment (epidural), although few of the differences in measures of pulmonary function actually attained statistical significance, except in the case of pulmonary complications. In the meta-analyses, there were no statistically significant differences in surrogate measures of pulmonary function (FEV,, FVC, and PEFR), but both the incidence of pulmonary infection (Fig. 2) and the incidence of pulmonary complications (Fig. 3) were significantly lower in the epidural group. Oxygenation was also significantly better overall in patients receiving the epidural treatment (Table l) , but without data on whether supplementary oxygen was given, it is difficult to interpret this finding.
Epidural Local Anesthetics with Opioids Versus Systemic Opioids
Only seven RCTs contained data on pulmonary function (not statistically significant), whereas Jayr et al. (45) reported no difference. With such a small number of trials, small number of patients, and inconclusive findings, it is not surprising that the meta-analyses did not produce significant results for this comparison.
Thoracic Versus Lumbar Epiduval Opioids
There are eight papers that make this comparison (14,47-53). There are few positive findings and no significant differences in the analgesic effects of the two treatments. Only Guinard et al. (14) found a statistically significant improvement in pulmonary function when catheters were placed in the thoracic region. In the meta-analyses, there were no clinically or statistically significant differences in analgesia or pulmonary function between thoracic and lumbar epidural opioids.
Intercostal Block Versus Systemic Opioid
Eleven papers contributed to these analyses (24,26, 54-62). Three potentially useful papers were excluded (82-84) because patients in these studies were also included in the updated study by Eng and Sabanathan (56). This was a difficult group to analyze because of differences in the treatments evaluated. Most examined the effect of a single (one time only) series of intercostal injections, but others used catheters and repeated the injections, or gave continuous infusions of a local anesthetic (54-56). In most of the studies, a systemic opioid was given on an as-needed basis to all patients (experimental and control), but in two of the studies (26,59), systemic medications were not given to patients receiving intercostal nerve blocks. However, because the measurements of pulmonary function we chose to analyze were taken within the likely duration of effectiveness of single-shot injections, before breakthrough medication was requested, we ignored these differences. Many investigators found statistically significant differences in surrogate measures of pulmonary function favoring the intercostal treatment (54,56-60,62), but overall, although differences do exist, none attained statistical significance.
With regard to the analyses of pulmonary complications, most studies claimed no statistically significant differences (26,55,57,60,61), the only exception being a decrease in pulmonary complications associated with the intercostal treatment found by Eng and Sabanathan (56). However, RRs calculated in the meta-analyses (0.47, P = 0.12 for pulmonary complications overall; 0.65, P = 0.34 for atelectasis) suggest a clinically significant benefit to intercostal nerve blockade in terms of pulmonary outcome. In view of the preponderance of positive studies, intercostal nerve blockade might be effective in improving certain measures of pulmonary function, but additional trials are required to produce statistically significant differences. The question arises as to whether intercostal nerve blockade should be chosen instead of epidural treatments. We discovered only three studies (24, 26, 85) A statistically significant increase in FEV, and FVC was the finding of three of the studies (70,74,75), but one (72) actually found a significant decrease in FEV, and FVC. In the meta-analyses, there was no demonstrable improvement in pulmonary function attributable to the intrapleural therapy (Table 1) . However, analgesia was improved by the intrapleural treatment in studies except that of Oxorn and Whatley (72). In aggregate, the evidence indicates that the intrapleural infusion of local anesthetics may be a useful alternative to epidural analgesia in providing analgesia, despite a lack of convincing evidence of an improvement in pulmonary function.
Discussion
We conducted a systematic review of the effects of various analgesic therapies on pulmonary function. Although a conventional narrative review article can tease out different aspects of the individual trials for scrutiny and comment, it has the disadvantage of relying on the subjective approach to literature retrieval and to interpretation of the available data. Hence, one does not come away with concrete, rigorous data in support of the overview (86). The principal weakness of our systematic, quantitative approach is that we were forced, to pool sufficient data for meaningful analyses, to combine studies that are heterogeneous POSTOPERATIVE ANALGESIA AND PULMONARY FUNCTION (i.e., varying design, differing patient populations, different therapeutic regimens, and different surgical groups) (Appendix 1). On the other hand, our primary goal was not to argue for the advantage of one therapy over another in one patient group, or one therapeutic group, or one surgical group over another, but rather to derive concrete measures of the effects of selected postoperative analgesic therapies on pulmonary function.
Few statistically significant differences were found in any of these meta-analyses (Table 1) . However, the differences that were found are important, being measures of outcome and concerning epidural treatments-the most widely used of the therapies under study. Other differences may reach statistical significance when more studies are available. We demonstrated a statistically significant decrease in the incidence of atelectasis in association with epidural opioid therapy (11 studies) (Fig. l) , and in the incidence of pulmonary infections (5 studies) and pulmonary complications overall (6 studies) in association with epidural local anesthetics (Figs. 2 and 3) . If we also examine the graphical depiction of the cumulative metaanalysis of the incidence of pulmonary complications in relation to epidural opioid treatment (Fig. 4) , a trend toward statistical significance seems to develop. If the evolution of the literature on pulmonary infections were to parallel that on atelectasis, the CI interval would decrease, and the effect would achieve significance as the number of available studies increased. Indeed, all of the variables analyzed herein show at least a trend in favor of the experimental treatments in terms of their effect on pulmonary function. With an increase in the number of well designed published trials, many of the measures could attain statistical significance in meta-analyses (87 by these studies. At the same time, the analgesic measures used in the trials we analyzed (i.e., measures of pain at rest) may be poor predictors of changes in pulmonary mechanics, whereas measures of pain with activity (i.e., during deep breathing or cough) might correlate better with pulmonary function (97). The effects of improved analgesia at rest, in themselves, do not seem to sufficiently account for improved pulmonary mechanics (Appendix l), but perhaps the picture would be different if other measures of pain and pulmonary function were used.
We should also note the improved Pao, during epidural local anesthetic treatment (difference 4.56 mm Hg, P = 0.047). Maintenance of adequate oxygenation is obviously important, particularly in the early postoperative period, when hypoxemia resulting from the effects of surgery and anesthesia is common and can provoke or exacerbate myocardial ischemia (98,99). Hypoxemia can be a devastating consequence of postoperative pulmonary dysfunction. Postoperative epidural analgesia using local anesthetics may be particularly beneficial because it avoids the use of respiratory depressant opioids. However, in the trials that we studied, there was little, if any, control of the use of supplementary oxygen. The results of an individual study that does control the use of supplementary oxygen (38) may be important (Appendix l), but whether our result can be taken as a true indication that the epidural local anesthetic treatment is superior in terms of oxygenation is debatable. Hence, because of the general inattention to the use of supplementary oxygen in the trials, the result of this metaanalysis must be viewed with caution.
We conclude that postoperative respiratory dysfunction is universally observed after abdominal and thoracic surgery (100-102 measures of pulmonary function did not reach statistical significance, but this could be due to either the small number of patients analyzed or the failure of the chosen measures to reflect pulmonary outcome. Perhaps for the same reasons, no significant differences were found for treatments other than epidural opioid and epidural local anesthetics.
Further analysis might help to outline possible correlations between pulmonary function and factors such as doses, volumes, and mixtures of drugs used; segmental level of anesthetic blockade; type of nerve block used; and area of peripheral neural blockade. However, such analyses are beyond the scope of this paper and would be unwarranted given the paucity of published RCTs. Despite these methodological difficulties, these meta-analyses provide convincing evidence that postoperative epidural analgesia can significantly decrease pulmonary morbidity. 
